National Cancer Institute   Cancer Therapy Evaluation Program   Developing Cancer Therapies
CTEP HomeContactHelpSearch:

Guidelines and Tools for Protocol Development

Investigators' Handbook

Letter of Intent (LOI)

Concept Submission

CTEP Review Types

List of Codes and Values

  • MedDRA Codes
  • Agent NSC Numbers
  • Country Codes
  • Cooperative Group Codes
  • Institution Codes

Specimen collection guidelines for breast cancer Group trials

Slow Accrual Guidelines for Phase III Trials

Slow Accrual Guidelines Development

Artifacts

Protocol Templates and Applications

  • Cytochrome P450 Drug Interaction Tables
  • Protocol Authoring Handbook
  • Phase I and II Templates
  • Phase III Template
  • Organ Dysfunction Templates
  • Protocol Submission Worksheet
  • Response Evaluation Criteria in Solid Tumors (RECIST)
  • Common Data Elements
  • CTCAE (formerly known as CTC) v2.0 and v3.0
  • Adverse Event Guidelines
  • Informed Consent Guidelines
  • CTEP Amendment Requests
  • Treatment Assignment Instructions and Guidelines

NCI Standard Protocol Language for Collaborative Agreements (MS Word)

Patient Confidential Disclosure Agreement (WordPerfect)

Patient Confidential Disclosure Agreement (MS Word)

Non-Protocol Access to Experimental Agents (MS Word)

Correlative Science Guidelines (MS Word)

Tier System Ancillary Studies (PDF)

Cooperative Group Common Budget Outline (MS Excel)

CTEP Conflict of Interest Policy for Cooperative Group Phase 3 Trials (PDF)

NCI Clinical Trials Cooperative Group Program Data Sharing Policy

NCI Clinical Trials Cooperative Group Program Guidelines for Development, Conduct and Analysis of Clinical Trials with International Collaborating Institutions (PDF)


  Home   |   Contact   |   Privacy Notice   |   Accessibility National Cancer Institute   National Institutes of Health   Department of Health and Human Services   USA.gov